SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-08-029525
Filing Date
2008-05-15
Accepted
2008-05-15 15:13:02
Documents
4
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 v113417_10q.htm 10-Q 405636
2 SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER v113417_ex31-1.htm EX-31.1 15270
3 SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER v113417_ex31-2.htm EX-31.2 15772
4 SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIA v113417_ex32-1.htm EX-32.1 9390
  Complete submission text file 0001144204-08-029525.txt   447608
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52998 | Film No.: 08836928
SIC: 2834 Pharmaceutical Preparations